|
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Next
|
|
| |
|
Mar '05
|
|
Alabama to Stop HIV Drugs for Hundreds
| |
An Alabama health official told state lawmakers last month that 514 HIV-positive people will be removed from the state's AIDS Drug Assistance Program in April unless the program receives an additional $3.5 million in funding. |
|
|
Mar '05
|
|
Nevirapine Safety Risks
| |
Food and Drug Administration advised physicians last month to weigh the risks and benefits of Viramune (nevirapine) before prescribing it. Cases of liver damage that produce rash, fever or other symptoms are more common with nevirapine than with other AIDS drugs, FDA said
in a statement. |
|
|
Mar '05
|
|
Merck Plans Human Vaccine Trials
| |
In a collaborative effort, Merck & Co., the HIV Vaccine Trials Network, and National Institutes of Allergy and Infectious Diseases are beginning phase II clinical trials of Merck's AIDS vaccine candidate MRKAd5 in the United States, Canada, Australia, Latin America, and the Caribbean.
|
|
|
Mar '05
|
|
Meds Prevent HIV Mutations
| |
Taking AIDS drugs exactly as prescribed is the best way to prevent HIV from becoming drug-resistant, researchers recently told an American Medical Association briefing. |
|
|
Feb '05
|
|
New Pain Drug from Snail Venom
| |
Last month, the Food and Drug Administration approved Prialt (ziconotide), a new drug for hard-to-treat pain associated with cancer, AIDS, and neuropathies that may improve pain management. |
|
|
Feb '05
|
|
HIV Treatment in One Daily Pill
| |
Drug firms Bristol-Myers Squibb Co. and Gilead Sciences Inc. have announced the formation of a joint venture to manufacture and test the first once-daily pill containing three common AIDS medicines from two different drug classes. |
|
|
Feb '05
|
|
Scientists Find Clue to AIDS Origins, New Therapy
| |
A single difference between a human gene and the one in rhesus monkeys that blocks HIV infection in the animals could offer both insight into the origins of the AIDS epidemic and a potential gene therapy, said authors of a study published last month. |
|
|
Feb '05
|
|
HIV Can Be Flushed Out of Hiding
| |
HIV has learned how to lie dormant in the body and escape the attack of AIDS drugs. |
|
|
Jan '05
|
|
Abbott Slammed on Kaletra Marketing
| |
The US Food and Drug Administration has ordered Abbott Laboratories to immediately suspend print ads for its AIDS drug Kaletra, accusing the company of exaggerating the medication's benefits. |
|
|
Jan '05
|
|
Anti-Gay Mind-Set Hindering AIDS Fight in Jamaica
| |
The New York-based Human Rights Watch issued a report saying that Jamaican government efforts to fight HIV/AIDS are being hampered by discrimination and violence against gays and HIV-positive people. |
|
|
Jan '05
|
|
Rare Sexually Transmitted Disease
| |
The Netherlands' National Institute for Public Health said that an outbreak of a rate STD among gay and bisexual men might also facilitate the transmission of HIV. |
|
|
Jan '05
|
|
Intermittent Viral Load "Blips" Largely Due to Assay Variation, Not Emerging Resistance
| |
The intermittent detection of viral load in patients who normally have undetectable viral loads (<50 copies/mL) has been referred to as "viral load blipping." There has been considerable concern among both patients and providers that these blips are early warning signs of
treatment failure and could be an early demonstration of the development of drug resistance. |
|
|
Jan '05
|
|
Oral Sex Syph on the Rise
| |
Syphilis is increasingly being transmitted through oral sex, according to a new CDC report. Mistaken in the belief that oral sex is safe sex, many people are unaware they can readily catch or transmit syphilis in this manner. Moreover, syphilitic sores in the mouth can increase the
risk of HIV infection. |
|
|
Dec '04
|
|
Tipranavir for PI Mutations?
| |
Tipranavir was found to have activity against many forms of PI-resistant virus in a recent study comparing the efficacy and safety of tipranavir (TPV), a new HIV-1 protease inhibitor (PI), combined with low-dose ritonavir (RTV, Norvir) to other boosted PI regimens. |
|
|
Dec '04
|
|
Truvada Slows HIV
| |
Gilead Sciences' once-daily combination antiretroviral drug Truvada is more effective at slowing the progression of HIV than GlaxoSmithKline's twice-daily antiretroviral Combivir, according to preliminary data. |
|
|
Dec '04
|
|
Treatment = Prevention?
| |
Taiwan's universal provision of antiretroviral drugs may be associated with a more than 50% reduction in the country's estimated HIV incidence rate, according to a study published in the
Journal of Infectious Diseases. |
|
|
Dec '04
|
|
Tenofovir Beats AZT
| |
For years, multiple HIV treatment guidelines have agreed with the well-supported approach of a dual-nucleoside backbone with either efavirenz (EFV, Sustiva, Stocrin) or a boosted protease inhibitor. |
|
|
Dec '04
|
|
Rosiglitazone causes lipomas in HIV-positive man with fat loss
| |
A drug which is being studied as a possible remedy for the fat loss which can be caused by anti-HIV drugs can cause lipomas, according to a recent case report. |
|
|
Nov '04
|
|
AIDS-Dementia Patients Lack Dopamine
| |
Scientists have detected depletion of the brain chemical dopamine in AIDS patients living with early indications of dementia. |
|
|
Nov '04
|
|
Fuzeon May See Attrition
| |
Despite widespread praise of Fuzeon's effectiveness, the AIDS drug has been afflicted by disappointing sales, bad reaction to the $20,000 per-patient annual price, needle fears among patients, and early manufacturing difficulties since its March 2003 Food and Drug
Administration approval. |
|
|
Nov '04
|
|
Heart Drugs May Target HIV
| |
Statins lower cholesterol levels and reduce the risk of heart disease. Now, new research from Spain indicates they may also fight HIV. |
|
|
Nov '04
|
|
Erythromycin Can Trigger Cardiac Deaths
| |
The antibiotic erythromycin dramatically increases the risk of cardiac arrest, especially when it is taken with certain newer drugs, including protease inhibitors. |
|
|
Nov '04
|
|
Tax Dollars Flow to Catholic Anti-Sex Preaching
| |
The Department of Health and Human Services has awarded the Catholic Diocese of Orlando's ThinkSmart abstinence program a three-year, $2.4 million grant. |
|
|
Nov '04
|
|
Love Me
| |
To "arrive" in America is to be marketed to. |
|
|
Oct '04
|
|
Parents Unaware of Teen Sex
| |
A national survey of US parents of youths ages 14-18 found that many are unaware their teens are sexually active. |
|
|
Oct '04
|
|
Even Drug-Resistant HIV Infection Responds to Right Treatment
| |
Thanks to research advances over the past decade, children born with HIV are now surviving into their teens and early adulthood. |
|
|
Oct '04
|
|
Bush Tries to Divert AIDS Funds to Christian Groups
| |
President Bush proposed that the executive branch assume greater power to decide where Ryan White Comprehensive AIDS Resource Emergency (CARE) Act funds are distributed and how they are spent. |
|
|
Oct '04
|
|
New HIV Therapy Approach
| |
An experimental drug helped to check the HIV enzyme integrase in monkeys, according to research published last month, a hopeful step in the fight to block HIV's reproduction and spread in humans. |
|
|
Oct '04
|
|
New Drug Mix for Hepatitis C and HIV
| |
A new hepatitis C (HCV) drug combination is more effective in guarding against liver damage in people coinfected with HIV than previous therapy, two studies released last month revealed. |
|
|
Oct '04
|
|
Diabetes Drug Eases HIV Treatment Effects
| |
The diabetes drug Avandia (rosiglitazone) might help reduce body fat redistribution and diabetes-like metabolic changes that can occur when patients are on certain AIDS cocktails, announced US researchers. |
|
|
|
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Next
|
Advertise with us
Subscriptions
Contact us
Site map
Translate
